AMERICAN STOCK EXCHANGE LISTS COMMON STOCK OF TIENS BIOTECH GROUP
New York, April 25, 2005 - The American Stock Exchange (Amex) today listed common shares of Tiens Biotech Group (USA), Inc. under the trading symbol "TBV." Tiens Biotech is engaged in the research, development, manufacturing and marketing of healthcare products including herbal products, vitamin and mineral supplements and personal care.
"We are pleased to welcome Tiens Biotech to the Amex where they join a growing roster of entrepreneurial pharmaceutical, biotech and medical-device companies that choose to list their shares here," Senior Vice President Amex Equities Group John McGonegal said, "The Amex also looks forward to helping Tiens Biotech bring its story to a greater number of investors."
"We are delighted to be listing on the American Stock Exchange which will mark another major milestone in our Company's history. We believe that our listing on the Amex will enhance the visibility of the Company, liquidity of our stock and will benefit our shareholders. We look forward to continuing to generate future domestic and international growth as we continue to capitalize on the growing popularity among consumers for our wellness and dietary supplement products worldwide," said Jinyuan Li, Chairman, chief executive officer.
The specialist in Tiens Biotech Group will be AGS Specialist Partners. For more information on Tiens Biotech Group, or any Amex-listed company, please visit www.amex.com.
|
